Clinical trials recruiting for Breast Cancer - Infiltrating Ductal Carcinoma
3
Recruiting trials
3
US states with sites
2
Countries
33%
Accept healthy volunteers
Phase breakdown
Phase 2 1Not applicable 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Concurrent endocrine therapy with the chemotherapy and HER2 directed therapy | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Oregon | 1 |
| Texas | 1 |
| Washington | 1 |
Top cities
Self-screener
Recruiting trials
- Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast Cancer
- Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery
- Validation of the Oncoliq Test for the Early Detection of Breast Cancer.
Related conditions
Trials recruiting for Breast Cancer - Infiltrating Ductal Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239HER-2 Positive Breast Cancer 4Breast-conserving Surgery 4Breast Cancer - Female 61Breast Cancer Early Stage Breast Cancer (Stage 1-3) 23Breast Cancer (Early Breast Cancer) 6
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Breast Cancer - Infiltrating Ductal Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.